JP Morgan Chase’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

JP Morgan Chase’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,400	Closed	-$427K	–	6062
2019 Q3	$427K	Buy	+4,400	New	+$441K	﹤0.01%	4242
2019 Q2	–	Sell	-63,500	Closed	-$7.23M	–	6150
2019 Q1	$7.23M	Buy	+63,500	New	+$4.67M	﹤0.01%	2310
2018 Q4	–	Sell	-30,000	Closed	-$1.64M	–	6067
2018 Q3	$1.64M	Buy	30,000 +3,000	+11%	+$205K	﹤0.01%	3600
2018 Q2	$2.23M	Sell	27,000 -3,000	-10%	-$232K	﹤0.01%	3335
2018 Q1	$2M	Buy	+30,000	New	+$1.73M	﹤0.01%	3271

JP Morgan Chase's ONCE Position: Q4 2019 in Review

JP Morgan Chase sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 499,936 shares — an estimated $48.5M sold.

JP Morgan Chase first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $191M in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

JP Morgan Chase reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
JP Morgan Chase sold 499,936 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $48.5M.
JP Morgan Chase first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
JP Morgan Chase's Spark Therapeutics, Inc. Common Stock position peaked at $191M in Q2 2018.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.